Last 12 months
Inside the activity.
3 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2019 Filed Feb 21, 2019 20:31 UTC |
Pelletier StephenExecutive Vice President
|
SaleCommon Stock | 5,026 | $94.01 | $472,494.26 |
DisclosureSEC source: 0001127602-19-007479 · form4.xml · nonDerivative · entry 3 Pelletier Stephen · CIK 0001602568 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,460 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.76 to $94.35, inclusive. The reporting person undertakes to provide to Prudential Financial, Inc., any security holder of Prudential Financial, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| February 20, 2019 Filed Feb 21, 2019 20:31 UTC |
Pelletier StephenExecutive Vice President
|
SaleCommon Stock | 3,491 | $94.03 | $328,258.73 |
DisclosureSEC source: 0001127602-19-007479 · form4.xml · nonDerivative · entry 2 Pelletier Stephen · CIK 0001602568 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,486 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.70 to $94.40, inclusive. The reporting person undertakes to provide to Prudential Financial, Inc., any security holder of Prudential Financial, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| February 20, 2019 Filed Feb 21, 2019 20:31 UTC |
Pelletier StephenExecutive Vice President
|
Exercise / conversionCommon Stock | 18,928 | $63.59 | $1,203,631.52 |
DisclosureSEC source: 0001127602-19-007479 · form4.xml · nonDerivative · entry 1 Pelletier Stephen · CIK 0001602568 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 21:17 UTC |
Pelletier StephenExecutive Vice President
|
SaleCommon Stock | 6,532 | $94.14 | $614,922.48 |
DisclosureSEC source: 0001127602-19-006797 · form4.xml · nonDerivative · entry 1 Pelletier Stephen · CIK 0001602568 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,049 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.98 to $94.33, inclusive. The reporting person undertakes to provide to Prudential Financial, Inc., any security holder of Prudential Financial, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. F2 · balance_after: Following the transaction reported on this Form 4, Mr. Pelletier continues to hold 15,049 shares directly and 625 shares indirectly in a 401(k) account. Mr. Pelletier also holds an additional 51,306 vested stock options, 119,540 unvested stock options, 34,166 deferred compensation shares, and 39,757 target performance shares (the exact number awarded being dependent on achievement of performance goals). Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:48 UTC |
TANJI KENNETHEVP and CFO
|
Grant2019 Performance Shares · Derivative | 8,355 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006069 · form4.xml · derivative · entry 6 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,355 Underlying: Common Stock · 8,355 shares Expires not disclosed F5 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. F6 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:48 UTC |
TANJI KENNETHEVP and CFO
|
Grant2019 Employee Stock Option (Right to Buy) · Derivative | 26,079 | $0.00 Strike: $93.36 | $0.00 |
DisclosureSEC source: 0001127602-19-006069 · form4.xml · derivative · entry 5 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,079 Underlying: Common Stock · 26,079 shares Expires 2029-02-12 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 12, 2020. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:48 UTC |
TANJI KENNETHEVP and CFO
|
Exercise / conversion2016 Performance Shares · Derivative | 2,909 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006069 · form4.xml · derivative · entry 4 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,909 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 3 filed with the SEC on December 10, 2018, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 3 filed with the SEC on December 10, 2018, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 3 filed with the SEC on December 10, 2018, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:48 UTC |
TANJI KENNETHEVP and CFO
|
Tax withholdingCommon Stock | 1,039 | $93.36 | $97,001.04 |
DisclosureSEC source: 0001127602-19-006069 · form4.xml · nonDerivative · entry 2 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,785 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:48 UTC |
TANJI KENNETHEVP and CFO
|
Exercise / conversionCommon Stock | 3,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006069 · form4.xml · nonDerivative · entry 1 TANJI KENNETH · CIK 0001760674 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 3 filed with the SEC on December 10, 2018, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:45 UTC |
STRANGFELD JOHN R JRDirector · NON-EXEC CHAIRMAN OF THE BOARD
|
Exercise / conversion2016 Performance Shares · Derivative | 41,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006066 · form4.xml · derivative · entry 5 STRANGFELD JOHN R JR · CIK 0001184679 · Director · NON-EXEC CHAIRMAN OF THE BOARD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,558 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:45 UTC |
STRANGFELD JOHN R JRDirector · NON-EXEC CHAIRMAN OF THE BOARD
|
Tax withholdingCommon Stock | 21,784 | $93.36 | $2,033,754.24 |
DisclosureSEC source: 0001127602-19-006066 · form4.xml · nonDerivative · entry 2 STRANGFELD JOHN R JR · CIK 0001184679 · Director · NON-EXEC CHAIRMAN OF THE BOARD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,194 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:45 UTC |
STRANGFELD JOHN R JRDirector · NON-EXEC CHAIRMAN OF THE BOARD
|
Exercise / conversionCommon Stock | 47,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006066 · form4.xml · nonDerivative · entry 1 STRANGFELD JOHN R JR · CIK 0001184679 · Director · NON-EXEC CHAIRMAN OF THE BOARD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:40 UTC |
Woods CandaceSenior Vice President
|
Grant2019 Performance Shares · Derivative | 1,768 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006061 · form4.xml · derivative · entry 6 Woods Candace · CIK 0001723202 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,768 Underlying: Common Stock · 1,768 shares Expires not disclosed F4 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F5 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. F5 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:40 UTC |
Woods CandaceSenior Vice President
|
Grant2019 Employee Stock Option (Right to Buy) · Derivative | 2,759 | $0.00 Strike: $93.36 | $0.00 |
DisclosureSEC source: 0001127602-19-006061 · form4.xml · derivative · entry 5 Woods Candace · CIK 0001723202 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,759 Underlying: Common Stock · 2,759 shares Expires 2029-02-12 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 12, 2020. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:40 UTC |
Woods CandaceSenior Vice President
|
Exercise / conversion2016 Performance Shares · Derivative | 555 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006061 · form4.xml · derivative · entry 4 Woods Candace · CIK 0001723202 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:40 UTC |
Woods CandaceSenior Vice President
|
Tax withholdingCommon Stock | 195 | $93.36 | $18,205.20 |
DisclosureSEC source: 0001127602-19-006061 · form4.xml · nonDerivative · entry 2 Woods Candace · CIK 0001723202 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,972 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:40 UTC |
Woods CandaceSenior Vice President
|
Exercise / conversionCommon Stock | 634 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006061 · form4.xml · nonDerivative · entry 1 Woods Candace · CIK 0001723202 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:37 UTC |
Sleyster ScottExecutive Vice President
|
Grant2019 Performance Shares · Derivative | 12,211 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006060 · form4.xml · derivative · entry 6 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,211 Underlying: Common Stock · 12,211 shares Expires not disclosed F5 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. F6 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:37 UTC |
Sleyster ScottExecutive Vice President
|
Grant2019 Employee Stock Option (Right to Buy) · Derivative | 38,115 | $0.00 Strike: $93.36 | $0.00 |
DisclosureSEC source: 0001127602-19-006060 · form4.xml · derivative · entry 5 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,115 Underlying: Common Stock · 38,115 shares Expires 2029-02-12 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 12, 2020. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:37 UTC |
Sleyster ScottExecutive Vice President
|
Exercise / conversion2016 Performance Shares · Derivative | 10,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006060 · form4.xml · derivative · entry 4 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,805 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:37 UTC |
Sleyster ScottExecutive Vice President
|
Tax withholdingCommon Stock | 4,045 | $93.36 | $377,641.20 |
DisclosureSEC source: 0001127602-19-006060 · form4.xml · nonDerivative · entry 2 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,753.12 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:37 UTC |
Sleyster ScottExecutive Vice President
|
Exercise / conversionCommon Stock | 12,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006060 · form4.xml · nonDerivative · entry 1 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,798.12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:36 UTC |
Silitch Nicholas CSenior Vice President
|
Grant2019 Performance Shares · Derivative | 8,998 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006059 · form4.xml · derivative · entry 6 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,998 Underlying: Common Stock · 8,998 shares Expires not disclosed F5 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. F6 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:36 UTC |
Silitch Nicholas CSenior Vice President
|
Grant2019 Employee Stock Option (Right to Buy) · Derivative | 14,043 | $0.00 Strike: $93.36 | $0.00 |
DisclosureSEC source: 0001127602-19-006059 · form4.xml · derivative · entry 5 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,043 Underlying: Common Stock · 14,043 shares Expires 2029-02-12 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 12, 2020. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:36 UTC |
Silitch Nicholas CSenior Vice President
|
Exercise / conversion2016 Performance Shares · Derivative | 10,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006059 · form4.xml · derivative · entry 4 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,805 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:36 UTC |
Silitch Nicholas CSenior Vice President
|
Tax withholdingCommon Stock | 4,978 | $93.36 | $464,746.08 |
DisclosureSEC source: 0001127602-19-006059 · form4.xml · nonDerivative · entry 2 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,174 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:36 UTC |
Silitch Nicholas CSenior Vice President
|
Exercise / conversionCommon Stock | 12,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006059 · form4.xml · nonDerivative · entry 1 Silitch Nicholas C · CIK 0001552178 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:34 UTC |
Pelletier StephenExecutive Vice President
|
Grant2019 Employee Stock Option (Right to Buy) · Derivative | 47,643 | $0.00 Strike: $93.36 | $0.00 |
DisclosureSEC source: 0001127602-19-006057 · form4.xml · derivative · entry 6 Pelletier Stephen · CIK 0001602568 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,643 Underlying: Common Stock · 47,643 shares Expires 2029-02-12 F6 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 12, 2020. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:34 UTC |
Pelletier StephenExecutive Vice President
|
Grant2019 Performance Shares · Derivative | 15,264 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006057 · form4.xml · derivative · entry 5 Pelletier Stephen · CIK 0001602568 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,264 Underlying: Common Stock · 15,264 shares Expires not disclosed F4 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F5 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. F5 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:34 UTC |
Pelletier StephenExecutive Vice President
|
Exercise / conversion2016 Performance Shares · Derivative | 18,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006057 · form4.xml · derivative · entry 4 Pelletier Stephen · CIK 0001602568 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:34 UTC |
Pelletier StephenExecutive Vice President
|
Tax withholdingCommon Stock | 8,293 | $93.36 | $774,234.48 |
DisclosureSEC source: 0001127602-19-006057 · form4.xml · nonDerivative · entry 2 Pelletier Stephen · CIK 0001602568 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,581 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:34 UTC |
Pelletier StephenExecutive Vice President
|
Exercise / conversionCommon Stock | 21,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006057 · form4.xml · nonDerivative · entry 1 Pelletier Stephen · CIK 0001602568 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:32 UTC |
Lowrey Charles FDirector · CEO and Chairman Elect
|
Grant2019 Performance Shares · Derivative | 26,671 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006056 · form4.xml · derivative · entry 6 Lowrey Charles F · CIK 0001512629 · Director · CEO and Chairman Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,671 Underlying: Common Stock · 26,671 shares Expires not disclosed F5 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. F6 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:32 UTC |
Lowrey Charles FDirector · CEO and Chairman Elect
|
Grant2019 Employee Stock Option (Right to Buy) · Derivative | 83,250 | $0.00 Strike: $93.36 | $0.00 |
DisclosureSEC source: 0001127602-19-006056 · form4.xml · derivative · entry 5 Lowrey Charles F · CIK 0001512629 · Director · CEO and Chairman Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,250 Underlying: Common Stock · 83,250 shares Expires 2029-02-12 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 12, 2020. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:32 UTC |
Lowrey Charles FDirector · CEO and Chairman Elect
|
Exercise / conversion2016 Performance Shares · Derivative | 19,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006056 · form4.xml · derivative · entry 4 Lowrey Charles F · CIK 0001512629 · Director · CEO and Chairman Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,740 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:32 UTC |
Lowrey Charles FDirector · CEO and Chairman Elect
|
Tax withholdingCommon Stock | 10,390 | $93.36 | $970,010.40 |
DisclosureSEC source: 0001127602-19-006056 · form4.xml · nonDerivative · entry 2 Lowrey Charles F · CIK 0001512629 · Director · CEO and Chairman Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,763 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:32 UTC |
Lowrey Charles FDirector · CEO and Chairman Elect
|
Exercise / conversionCommon Stock | 22,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006056 · form4.xml · nonDerivative · entry 1 Lowrey Charles F · CIK 0001512629 · Director · CEO and Chairman Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:35 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Grant2019 Performance Shares · Derivative | 4,499 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006058 · form4.xml · derivative · entry 2 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,499 Underlying: Common Stock · 4,499 shares Expires not disclosed F2 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F3 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. F3 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:35 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Grant2019 Employee Stock Option (Right to Buy) · Derivative | 7,022 | $0.00 Strike: $93.36 | $0.00 |
DisclosureSEC source: 0001127602-19-006058 · form4.xml · derivative · entry 1 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,022 Underlying: Common Stock · 7,022 shares Expires 2029-02-12 F1 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 12, 2020. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:31 UTC |
Koster BarbaraSenior Vice President
|
Grant2019 Performance Shares · Derivative | 4,419 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006054 · form4.xml · derivative · entry 6 Koster Barbara · CIK 0001520806 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,419 Underlying: Common Stock · 4,419 shares Expires not disclosed F5 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. F6 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:31 UTC |
Koster BarbaraSenior Vice President
|
Grant2019 Employee Stock Option (Right to Buy) · Derivative | 6,896 | $0.00 Strike: $93.36 | $0.00 |
DisclosureSEC source: 0001127602-19-006054 · form4.xml · derivative · entry 5 Koster Barbara · CIK 0001520806 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,896 Underlying: Common Stock · 6,896 shares Expires 2029-02-12 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 12, 2020. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:31 UTC |
Koster BarbaraSenior Vice President
|
Exercise / conversion2016 Performance Shares · Derivative | 5,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006054 · form4.xml · derivative · entry 4 Koster Barbara · CIK 0001520806 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,715 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:31 UTC |
Koster BarbaraSenior Vice President
|
Tax withholdingCommon Stock | 2,031 | $93.36 | $189,614.16 |
DisclosureSEC source: 0001127602-19-006054 · form4.xml · nonDerivative · entry 2 Koster Barbara · CIK 0001520806 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,651 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:31 UTC |
Koster BarbaraSenior Vice President
|
Exercise / conversionCommon Stock | 6,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006054 · form4.xml · nonDerivative · entry 1 Koster Barbara · CIK 0001520806 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:29 UTC |
Harris Timothy PEVP and General Counsel
|
Grant2019 Performance Shares · Derivative | 8,837 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006052 · form4.xml · derivative · entry 6 Harris Timothy P · CIK 0001653998 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,837 Underlying: Common Stock · 8,837 shares Expires not disclosed F5 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. F6 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:29 UTC |
Harris Timothy PEVP and General Counsel
|
Grant2019 Employee Stock Option (Right to Buy) · Derivative | 13,792 | $0.00 Strike: $93.36 | $0.00 |
DisclosureSEC source: 0001127602-19-006052 · form4.xml · derivative · entry 5 Harris Timothy P · CIK 0001653998 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,792 Underlying: Common Stock · 13,792 shares Expires 2029-02-12 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 12, 2020. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:29 UTC |
Harris Timothy PEVP and General Counsel
|
Exercise / conversion2016 Performance Shares · Derivative | 8,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006052 · form4.xml · derivative · entry 4 Harris Timothy P · CIK 0001653998 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.exercise_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. F1 · derivative.expiration_date: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:29 UTC |
Harris Timothy PEVP and General Counsel
|
Tax withholdingCommon Stock | 2,935 | $93.36 | $274,011.60 |
DisclosureSEC source: 0001127602-19-006052 · form4.xml · nonDerivative · entry 2 Harris Timothy P · CIK 0001653998 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,249 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:29 UTC |
Harris Timothy PEVP and General Counsel
|
Exercise / conversionCommon Stock | 9,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006052 · form4.xml · nonDerivative · entry 1 Harris Timothy P · CIK 0001653998 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee awarded these shares, the grant of which was made on February 9, 2016, and originally reported on a Form 4 filed with the SEC on February 11, 2016, based upon performance relative to the average Return On Equity (ROE) goals modified by ROE, EPS Growth and Book Value Per Share Growth relative to certain life insurance peers during the 2016 through 2018 performance period. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 22:27 UTC |
GRIER MARK BDirector · Vice Chairman
|
Grant2019 Performance Shares · Derivative | 25,707 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006050 · form4.xml · derivative · entry 6 GRIER MARK B · CIK 0001184670 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,707 Underlying: Common Stock · 25,707 shares Expires not disclosed F5 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. F6 · derivative.expiration_date: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2019 through 2021 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.